BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29240299)

  • 1. The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler).
    Javed A; Aslam T; Jones SA; Mercer J; Tyler K; Church H; Ghosh A; Wynn R; Sornalingam K; Ashworth J
    Acta Ophthalmol; 2018 Aug; 96(5):494-498. PubMed ID: 29240299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the ocular phenotype in mucopolysaccharidosis.
    Sornalingam K; Javed A; Aslam T; Sergouniotis P; Jones S; Ghosh A; Ashworth J
    Br J Ophthalmol; 2019 Apr; 103(4):504-510. PubMed ID: 30120129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.
    Pal AR; Langereis EJ; Saif MA; Mercer J; Church HJ; Tylee KL; Wynn RF; Wijburg FA; Jones SA; Bruce IA; Bigger BW
    Orphanet J Rare Dis; 2015 Apr; 10():42. PubMed ID: 25887468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT).
    Guffon N; Pettazzoni M; Pangaud N; Garin C; Lina-Granade G; Plault C; Mottolese C; Froissart R; Fouilhoux A
    Orphanet J Rare Dis; 2021 Jan; 16(1):60. PubMed ID: 33517895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Bloodstream Infections after Hematopoietic Stem Cell Transplantation for Hurler Syndrome.
    Dunseath C; O'Connor G; Mahulkar S; Badia P; Koo J; Dandoy CE
    Transplant Cell Ther; 2023 Nov; 29(11):707.e1-707.e4. PubMed ID: 37582469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
    Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
    Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.
    Moreau J; Brassier A; Amaddeo A; Neven B; Caillaud C; Chabli A; Fernandez-Bolanos M; Olmo J; Valayannopoulos V; Fauroux B
    Mol Genet Metab; 2015 Dec; 116(4):275-80. PubMed ID: 26602600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Hip Dysplasia in Mucopolysaccharidosis Type I Hurler After Successful Hematopoietic Stem Cell Transplantation.
    Langereis EJ; den Os MM; Breen C; Jones SA; Knaven OC; Mercer J; Miller WP; Kelly PM; Kennedy J; Ketterl TG; O'Meara A; Orchard PJ; Lund TC; van Rijn RR; Sakkers RJ; White KK; Wijburg FA
    J Bone Joint Surg Am; 2016 Mar; 98(5):386-95. PubMed ID: 26935461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of organ manifestations upon enzyme replacement therapy in a patient with mucopolysaccharidosis type I/Hurler.
    Mercimek-Mahmutoglu S; Reilly C; Human D; Waters PJ; Stoeckler-Ipsiroglu S
    World J Pediatr; 2009 Nov; 5(4):319-21. PubMed ID: 19911152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler.
    Ferrara G; Maximova N; Zennaro F; Gregori M; Tamaro P
    Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.
    Schmidt M; Breyer S; Löbel U; Yarar S; Stücker R; Ullrich K; Müller I; Muschol N
    Orphanet J Rare Dis; 2016 Jul; 11(1):93. PubMed ID: 27392569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open issues in Mucopolysaccharidosis type I-Hurler.
    Parini R; Deodato F; Di Rocco M; Lanino E; Locatelli F; Messina C; Rovelli A; Scarpa M
    Orphanet J Rare Dis; 2017 Jun; 12(1):112. PubMed ID: 28619065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular findings in four children with mucopolysaccharidosis I-Hurler (MPS I-H) treated early with haematopoietic stem cell transplantation.
    Fahnehjelm KT; Törnquist AL; Malm G; Winiarski J
    Acta Ophthalmol Scand; 2006 Dec; 84(6):781-5. PubMed ID: 17083538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler).
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2012 May; 90(3):287-90. PubMed ID: 20553232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I.
    Watson HA; Holley RJ; Langford-Smith KJ; Wilkinson FL; van Kuppevelt TH; Wynn RF; Wraith JE; Merry CL; Bigger BW
    J Biol Chem; 2014 Dec; 289(52):36194-203. PubMed ID: 25359774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.
    Aldenhoven M; de Koning TJ; Verheijen FW; Prinsen BH; Wijburg FA; van der Ploeg AT; de Sain-van der Velden MG; Boelens J
    Biol Blood Marrow Transplant; 2010 May; 16(5):701-4. PubMed ID: 20096360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease.
    Church H; Tylee K; Cooper A; Thornley M; Mercer J; Wraith E; Carr T; O'Meara A; Wynn RF
    Bone Marrow Transplant; 2007 Feb; 39(4):207-10. PubMed ID: 17220904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.